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Abstract 
Negative symptoms are often enduring and lead to poor functional outcomes in individuals with 
schizophrenia. The cognitive model of negative symptoms proposes that low expectancies of 
success contribute to the development and maintenance of negative symptoms; however, 
longitudinal investigations assessing these beliefs and negative symptoms are needed. The 
current study examined whether an individual’s baseline expectancies of success––one’s beliefs 
about future success and goal attainment––predicted negative symptom reduction over 18 
months in individuals with schizophrenia-spectrum disorders (n = 118). Data were collected at 
baseline, 9 months, and 18 months as part of a randomized controlled trial of Illness 
Management and Recovery. A mixed effects regression analysis revealed a significant reduction 
in negative symptoms over time, with a significant interaction effect between time and baseline 
expectancies of success. After controlling for baseline negative symptoms, demographic 
variables, and treatment conditions, those with high and moderate baseline expectancies of 
success evidenced a significant reduction in negative symptoms at 18 months, while those with 
low baseline expectancies of success did not evidence reduced negative symptoms. Findings 
support the cognitive model of negative symptoms and suggest that expectancies of success may 
be a useful treatment target for interventions aimed at reducing negative symptoms.  
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1. Introduction 
Negative symptoms such as reduced initiation of goal directed behaviors, pursuit of 
pleasurable experiences, and social interest and engagement, are often linked to poor functional 
outcomes. Indeed, negative symptoms have been linked to poor quality of life in individuals with 
schizophrenia (Hunter and Barry, 2012; Foussias et al., 2014), decreased independent living, 
functional capacity, and social and role functioning (Pogue-Geile and Harrow, 1985; Bowie et 
al., 2006; Kring et al., 2013; Fervaha et al., 2014). Moreover, evidence shows that negative 
symptoms contribute to poor functioning more than positive symptoms of schizophrenia 
(Rabinowitz et al., 2012). Approximately 60% of individuals with schizophrenia-spectrum 
disorders experience one or more negative symptoms (Bobes et al., 2010) and 15-20% 
experience enduring negative symptoms that are primary to the disorder (Buchanan, 2007). 
Although recent psychosocial treatments have shown efficacy in improving a subset of negative 
symptoms (Grant et al., 2012; Granholm et al., 2014; Grant et al., 2014), negative symptoms can 
often persist despite psychosocial treatments and antipsychotic medication (Tandon et al., 2010).  
The cognitive model of negative symptoms of schizophrenia suggests that one potential 
psychological mechanism that plays a role in the development and maintenance of negative 
symptoms is dysfunctional beliefs. Specifically, negative symptoms are thought to develop from 
dysfunctional beliefs about performance, acceptance, likelihood of success, and resources 
(Rector et al., 2005; Beck et al., 2009), which reduce motivation and effort for tasks of every-day 
living. Indeed, several cross-sectional studies have garnered support for the cognitive model of 
negative symptoms, with much of the evidence looking at a subtype of dysfunctional beliefs, 
defeatist performance beliefs (i.e., overgeneralized negative beliefs about one’s ability to 
successfully perform tasks). Defeatist performance beliefs are reported more frequently by 
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individuals with schizophrenia than by people without schizophrenia (Grant and Beck, 2009; 
Horan et al., 2010). Also, increased defeatist performance beliefs are associated with increased 
negative symptoms in individuals with schizophrenia (Grant and Beck, 2009; Horan et al., 2010; 
Couture et al., 2011; Quinlan et al., 2014), even when depression is controlled (Rector, 2004). 
Moreover, defeatist performance beliefs have been found to mediate the relationship between 
cognitive performance and both negative symptoms and functioning (Grant and Beck, 2009), as 
well as mediate the relationship between the capacity to perform everyday functional behaviors 
and negative symptoms (Horan et al., 2010). Longitudinal investigations of defeatist 
performance beliefs in individuals with schizophrenia have largely been conducted in the context 
of cognitive therapy clinical trials, which have found some support for an association between a 
reduction in defeatist performance beliefs and improved negative symptoms and functioning 
over time (Granholm et al., 2013; Granholm et al., 2014). However, the longitudinal relationship 
between negative symptoms and other types of dysfunctional beliefs remains unclear.      
Consistent with the cognitive model of negative symptoms, one’s expectancies of success 
may also be linked to the development and maintenance of negative symptoms (Rector et al., 
2005; Beck et al., 2009). Expectancies of success involve one’s beliefs about the likelihood of 
being successful and attaining goals in the future. Indeed, believing that one can meet their own 
goals or can succeed at a task would likely affect negative symptoms, as it would impact one’s 
motivation to initiative and sustain goal-directed behavior. Moreover, cross-sectional research 
has identified a link between low expectancies of success and increased negative symptoms 
(Couture et al., 2011); however, no studies to our knowledge have conducted longitudinal 
examinations of these beliefs and their relationships with negative symptoms. Previous research 
has also focused more on beliefs about general or task-related abilities (i.e., defeatist 
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performance beliefs) and less on an individual’s beliefs about the future and goals or 
expectancies of success, which is of increased importance given the prominence placed on 
setting and achieving goals in psychosocial treatments that promote recovery and target negative 
symptoms (e.g. Mueser and Gingerich, 2002; Grant et al., 2012). In fact, setting and making 
progress towards goals has been viewed as the ―catalyst‖ for recovery and a means to promote 
negative symptom improvement (Clarke et al., 2009; Grant et al., 2014). Therefore, additional 
research elucidating the role of beliefs about goals on negative symptoms and goal setting is 
needed.  
Moreover, an individual’s expectancies of success may impact the course of goal-setting 
and psychosocial treatment. Given that individuals engaged in treatment may be at various stages 
of change (Prochaska and DiClemente, 1994), they may be more or less engaged in initial 
treatment goal-setting. That is, individuals who are still contemplating change may not have or 
be aware of clear goals, while those who are more determined or motivated to change may have 
a greater sense of the types of goals that are meaningful goals that they want to pursue. However, 
if an individual is not ready or motivated to change or does not believe that they can achieve 
their goals, clinician led goal-setting is more likely to fail (Miller and Rollnick, 1991). Similarly, 
if the goal is not personally set and identified by the consumer, goal-setting and ultimately 
treatment based on those goals is likely to be less effective unless adequate justification is 
provided and described by the clinician (Locke and Latham, 2002). Therefore, one’s pre-
treatment expectancies of success may be an indicator of one’s readiness to identify and pursue 
meaningful goals, and it may be a driving force for future actions. Consequently, identifying the 
impact of an individual’s expectancies of success on treatment outcomes is critical.  
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Based on the cognitive model of negative symptoms (Rector et al., 2005; Beck et al., 
2009), the current study aimed to clarify the longitudinal relationship between expectancies of 
success and negative symptoms. Specifically, we conducted a secondary data analysis examining 
the predictive relationship of consumer expectancies of success for negative symptom reduction 
over an 18 month period. Given identified links between expectancies of success and concurrent 
negative symptoms (Couture et al., 2011), we first hypothesized that baseline consumer 
expectancies of success would predict negative symptom reduction over time (main effect). 
Next, we hypothesized that the level of negative symptom reduction would vary based on 
baseline expectancies of success, with higher baseline expectancies of success leading to a 
greater reduction in negative symptoms over time (interaction effect).   
2. Methods 
2.1. Participants  
We conducted a secondary data analysis of data from a randomized controlled trial 
comparing Illness Management and Recovery (IMR) to a problem solving group, which served 
as an active control condition. The IMR curriculum (Gingerich and Mueser, 2006) was used to 
guide the IMR condition and included goal setting for personal recovery goals. No formal 
curriculum or goal setting was used in the problem solving condition; participants were 
encouraged to discuss current concerns and obtained support for solving problems. Additional 
information about study conditions is available in Salyers et al. (2014). Participants consisted of 
118 individuals; sixty participants were randomized to the IMR condition, while 58 were 
randomized to the active control condition. Each condition met weekly for 9 months. 
Assessments were completed at baseline (pre-intervention) and 9 and 18 months later. Eligibility 
criteria included a diagnosis of schizophrenia or schizoaffective disorder based on the Structured 
Clinical Interview for DSM-IV (First et al., 1996), being at least 18 years old, no evidence of 
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severe cognitive dysfunction based on a cognitive screener (Callahan et al., 2002), current 
participation in mental health services at a VA medical center or a community mental health 
center, and no health condition(s) that would prohibit participation in an 18 month study. The 
sample had a mean age of 47.7 (SD = 8.9) and predominantly consisted of African American (n 
= 72, 61%) males (n = 94, 80%). Participants had diagnoses of schizophrenia (n = 54, 46%) or 
schizoaffective (n = 64, 54%) disorders and were receiving services at either an urban 
community mental health center (n = 66, 56%) or VA hospital (n = 52, 44%). Most participants 
were unemployed (n = 101, 86%), not currently married or living with a partner (n = 99, 84%), 
completed high school/GED or less (n = 79, 67%), and had an annual income below $20,000 (n 
= 99, 84%). Results from the original study found that there were no experimental differences 
between groups on outcomes over time, though both groups evidenced a significant reduction in 
negative symptoms over time; results and additional participant characteristics are described in 
more detail elsewhere (Salyers et al., 2014). The original study was approved by the local 
Institutional Review Boards. 
2.2. Measures  
2.2.1. Negative symptoms were measured using the eight-item negative symptoms subscale 
(Bell et al., 1994) of the interview-based Positive and Negative Syndrome Scale (PANSS; Kay et 
al., 1987). Items on the subscale include passive/apathetic social withdrawal, emotional 
withdrawal, blunted affect, lack of spontaneity and flow of conversation, poor rapport, 
disturbance of volition, preoccupation, and motor retardation. Ratings were completed by trained 
research personnel who achieved inter-rater reliability of .80 prior to completing study 
interviews. The PANSS has demonstrated satisfactory test-retest reliability, internal consistency, 
and validity in individuals with schizophrenia (Kay et al., 1987), and the negative symptom 
subscale showed adequate internal consistency in the current sample (α = .73).  
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2.2.2. Expectancies of Success were assessed using the 5-item goal and success orientation 
subscale from the self-report Recovery Assessment Scale (RAS; Corrigan et al., 1999; Corrigan 
et al., 2004). This subscale taps important beliefs about the likelihood of being successful and 
attaining goals in the future that likely play an important role in prospective negative symptoms. 
Sample items include, ―I have goals in life that I want to reach,‖ ―I have a desire to succeed,‖ and 
―I believe I can meet my current personal goals.‖ This subscale assesses beliefs akin to low 
expectancies of success, which are predicted by the cognitive model to have an important role in 
maintenance and development of negative symptoms (Rector et al., 2005; Beck et al., 2009), 
with the main difference being that expectancies of success are positively phrased. Thus, for 
conceptual clarity, we will refer to this subscale as expectancies of success throughout the 
manuscript. Although the primary predictor variable was the subscale reflecting expectancies of 
success, we also examined the other subscales of the RAS to explore whether the relationship 
was specific to expectancies of success or also applicable to other subscales of the RAS.  The 
RAS has shown good test-retest reliability and internal consistency in individuals with severe 
mental disorders (Corrigan et al., 1999).  In the current sample, the internal consistency for each 
of the RAS subscales was adequate: expectancies of success subscale  (α = .75), personal 
confidence and hope (α = .88), willingness to ask for help (α = .83), reliance on others (α = .72), 
and no domination by symptoms (α = .54).   
2.3. Data analysis 
  We first confirmed changes in negative symptoms and expectancies of success over time 
and across treatment groups. Then, we tested our hypotheses that expectancies of success predict 
a reduction in negative symptoms over 18 months (main effect) and the level of change depends 
upon the baseline expectancies of success status (interaction effect). We conducted a mixed 
EXPECTANCIES OF SUCCESS AND NEGATIVE SYMPTOMS                                                        9
effects regression analysis (random intercept model), controlling for baseline negative 
symptoms, demographic variables, and randomized treatment conditions. An interaction between 
time and baseline expectancies of success was included in the model. To aid in interpreting the 
results, we graphed the change in negative symptoms over time at three levels of baseline 
expectancies of success (low = 1SD below the mean, moderate = mean, and high = 1SD above 
the mean) for participants with average baseline negative symptoms. For the interpretability, the 
predictors were mean centered. After confirming changes in negative symptoms and 
expectancies of success across groups, all analyses were conducted with the entire sample. To 
examine the specificity of expectancies of success to negative symptoms, we also conducted four 
additional mixed effects regression analyses controlling for the aforementioned variables with 
each of the other four subscales from the RAS. Full Information Maximum Likelihood 
Estimation method was used to accommodate missing data. SAS ver. 9.3 was used for analyses. 
3. Results  
Consistent with the parent study, negative symptoms significantly decreased over 18 
months (p < .05, baseline M = 19.11, SD = 5.54; 9 months M = 18.20, SD = 5.98; and 18 months 
M = 17.54, SD = 6.77) but overall expectancies of success did not significantly change over 18 
months (p > .05; baseline 3.26, SD = .45; 9 months: 3.33, SD = .52; 18 months: 3.31, SD = .55). 
Notably, neither negative symptoms (p > .05) nor expectancies of success (p > .05) differed over 
time across treatment conditions. As shown in Table 1, negative symptoms decreased over time 
(β = -.80, p = .02) for participants with average baseline expectancies of success. Further, a two–
way interaction was found between time and baseline expectancies of success (β = -1.95, p = 
.01). Thus, the time effect varied as a function of baseline expectancies of success (see Table 1 & 
Figure 1). More specifically, after controlling for baseline negative symptoms, demographic 
variables, and treatment condition, higher levels of baseline expectancies of success were 
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associated with a steeper decrease in negative symptoms over 18 months. For participants with 
high and moderate expectancies of success, negative symptoms decreased significantly over time 
(p < .001 and p < .05 and, respectively), but for those with low expectancies of success, a 
significant negative symptom reduction was not observed (p = .95). None of the demographic 
variables or treatment conditions were significant in the model. We also explored whether these 
effects on 18 month negative symptoms were specific to the expectancies of success subscale or 
were more broadly applicable to the other RAS subscales; mixed effects regression analyses also 
controlling for baseline negative symptoms, demographic variables, and treatment conditions 
revealed that no other baseline subscales of the RAS were significant predictors of negative 
symptoms at 18 months (personal confidence and hope (p = .23); willingness to ask for help (p = 
.14); reliance on others (p = .27); no domination by symptoms (p = .95).   
4. Discussion  
Our findings indicate that an individual’s beliefs about the likelihood of being successful 
and meeting personal goals in the future (i.e., one’s expectancies of success) can yield important 
information about future negative symptoms. Although the mean level of negative symptoms 
reduced overtime, as hypothesized, higher baseline expectancies of success predicted greater 
reductions in negative symptoms over time. Holding baseline negative symptoms, demographic 
variables, and treatment condition constant, participants with high or moderate levels of baseline 
expectancies of success had significantly less negative symptoms over time, while participants 
with low levels of baseline expectancies of success did not improve in negative symptoms over 
time. Therefore, greater levels of baseline expectancies of success appeared to facilitate greater 
reductions in negative symptoms 18 months later. Further, beliefs about recovery did not predict 
a reduction in negative symptoms over time. Overall, the findings are consistent with a previous 
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cross-sectional study that found that low expectancies for success were positively correlated with 
diminished experience negative symptoms or anhedonia, asociality, and avolition (Couture et al., 
2011). Our study builds upon those findings by examining the prospective relationship between 
expectancies of success and negative symptoms.  
An additional key finding was that the level of expectancies of success did not 
significantly change over time even though participants were engaged in psychosocial treatment. 
Further, there were no differences in expectancies of success over time by treatment condition. 
Though these findings are consistent with a previous study that found significant symptom 
reduction despite no changes in a measure of recovery for participants with severe mental 
disorders who engaged in a self-management program (Fukui et al., 2011), these findings are 
particularly surprising given that a critical element of IMR is goal-setting with frequent follow-
up, while the control group did not address goals (Mueser and Gingerich, 2002; McGuire et al., 
in press). Thus, we would have expected to see changes in expectancies of success in the IMR 
condition but not the active control condition. One possible explanation is that although 
cognitive behavioral and motivational enhancement techniques are components of IMR that may 
facilitate change in expectancies of success over time, it is possible that the dose of each of these 
techniques was inadequate. Alternatively, it may be that deficits in metacognitive capacity 
(Lysaker et al., 2005), autobiographical memory (Berna et al., 2011), or poor self-integration 
(McGuire and Lysaker, in press) were important but unmeasured components. Indeed, deficits in 
metacognitive capacities can produce difficulties in one’s abilities to form complex ideas about 
themselves and about the future. Thus, it may be that no change was seen in expectancies of 
success, as these deficits can complicate the formation of goals and engagement in goal-directed 
behavior.  
EXPECTANCIES OF SUCCESS AND NEGATIVE SYMPTOMS                                                        12
Our findings also suggest that those with different levels of expectancies of success might 
differentially benefit from interventions. Indeed, despite the effectiveness of the interventions 
(IMR and the active control condition) in reducing negative symptoms, those with lower baseline 
expectancies of success did not appear to benefit from the interventions to the same extent of 
those with higher baseline expectancies of success. Therefore, those with lower levels of 
expectancies of success might need particular attention early on in order to obtain full benefits 
from interventions. Specifically, given that the interventions used in this study did not directly 
target negative beliefs about success, those with low levels of expectancies of success may 
benefit from techniques or interventions that focus on modifying beliefs to reduce negative 
symptoms (e.g. Grant et al., 2012; Granholm et al., 2013). Alternatively, given the identified 
links between low metacognitive capacity and both reduced intrinsic motivation (Vohs and 
Lysaker, 2014) and concurrent and prospective negative symptoms (Tas et al., 2012; McLeod et 
al., 2014) it may be that those with lower baseline expectancies of success would benefit from an 
integrated psychotherapy that aims to develop the degree to which persons form complex and 
integrated ideas about themselves, their future, and their goals (Lysaker et al., 2010). Future 
studies should seek to examine how more targeted interventions impact an individual’s 
expectancies of success over time and if similar patterns across individuals with different levels 
of negative symptoms are observed.  
The observed link between expectancies of success and future negative symptoms and 
lack of relationship between other types of beliefs and negative symptoms highlights the 
importance of assessing one’s expectancies of success in individuals with schizophrenia. Given 
that these beliefs can be assessed with a five-item self-report questionnaire, this measure may 
provide clinicians and researchers with an efficient way to measure consumers’ perceptions 
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about achievable goals. For example, if participants do not endorse these beliefs, clinicians may 
then provide more targeted interventions that aim to develop mastery and success (Beck et al., 
2009) to enhance an individual’s belief that they can set and achieve goals. In addition, this 
measure is also shorter than many other measures that assess for dysfunctional beliefs such as the 
Dysfunctional Attitudes Questionnaire (Weissman and Beck, 1978) or the Success and Resource 
Appraisals Questionnaire (Couture et al., 2007), perhaps enhancing its clinical utility. In 
addition, the expectancies of success subscale uses positively phrased items instead of negatively 
phrased items, which can reduce confusion (Colosi, 2005). This is especially pertinent for 
individuals with schizophrenia, who may experience cognitive deficits that interfere with the 
ability to accurately interpret complicated questions. However, future work is needed to directly 
compare the relationship and psychometric properties, including predictive validity, of these 
measures. 
Findings from this study should also be interpreted in light of several limitations. First, 
this is a secondary analysis of existing data and therefore was not designed to rigorously examine 
factors that predict negative symptom reduction. While the PANSS is a widely used measure of 
negative symptoms, it focuses largely on behavioral deficits and does not adequately capture an 
individual’s internal experience to fully evaluate negative symptoms (Blanchard et al., 2010). 
Future studies should aim to replicate these findings using more novel instruments of negative 
symptoms, such as the Clinical Assessment Interview for Negative Symptoms (CAINS; Horan et 
al., 2011; Kring et al., 2013) that include assessments of internal experiences. Second, our 
predictor variable, expectancies of success from the RAS, has face validity, but its relationship to 
other measures of expectancies and dysfunctional beliefs is unknown. Additional work is needed 
to verify the validity of this measure as an indicator of expectancies. In addition, other variables 
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or outcomes may be important to consider in future studies. For example, illness-related factors 
such as co-morbid depression, length of time diagnosed, and medication use may be predictive of 
negative symptoms.    
The current study provides additional support for the cognitive model of negative 
symptoms, demonstrating that one’s beliefs about the likelihood of being successful and meeting 
personal goals in the future was prospectively related to reduced negative symptoms. This study 
builds on prior studies by examining the longitudinal relationship between negative symptoms 
and expectancies of success. Indeed, this is one of the only studies we know of to examine 
expectancies of success and negative symptoms over time. We found that expectancies of 
success can predict an individual’s level of negative symptoms over an 18 month period. Further, 
we found that expectancies of success have specificity to prospective negative symptoms. These 
findings suggest that targeting an individual’s beliefs about the likelihood of future success and 
goal attainment might be a means of reducing negative symptoms in individuals with 
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 Main Effects Only Main Effects + Interactions 
  β SE t p β SE t p 
Intercept 20.96 2.08 10.08 <.0001 20.63 2.00 10.30 <.0001 
Time -.80 .35 -2.27 .02 -.85 .33 -2.59 .01 
Treatment Condition
 
 -.49 .65 -.75 .46 -.46 .63 -.72 .47 
Site .67 .75 .89 .37 .98 .73 1.35 .18 
Age  -.04 .04 -.90 .37 -.03 .04 -.80 .43 
Gender  .46 .83 .55 .58 .42 .80 .52 .60 
Race  -.14 .71 -.20 .84 -.02 .69 -.03 .97 
Education  -.80 .77 -1.04 .30 -.92 .74 -1.24 .22 
Baseline Negative 
Symptoms .61 .06 9.58 <.0001 .88 .08 11.46 <.0001 
Baseline  
Expectancies of 
Success -1.52 .75 -2.02 .05 .11 .93 .12 .91 
Time*Baseline 
Negative Symptoms         -.35 .06 -5.77 <.0001 
Time*Baseline  
Expectancies of 
Success         -1.95 .71 -2.74 .01 
Note: Baseline variables were used unless otherwise noted; Variables are coded as follows: Time – 0 = baseline, 1 = 9 
months, and 2 = 18 months; Treatment Condition – 0 = Active Control Group, 1 = Illness Management and Recovery; 
Site - 0 = Veterans Administration Medical Center, 1 = Community Mental Health Clinic; Gender – 0 = Female, 1 = 
Male; Race – 0 = Non-Caucasian, 1 = Caucasian; Education – 0 = Less than high school, 1 =More than high school; 
Negative symptoms = Negative symptoms subscale of Positive and Negative Syndrome Scale; Expectancies of Success 
= Goal and success orientation subscale of Recovery Assessment Scale.  
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Low Expectancies of Success, β = .03, n.s.   
Moderate Expectancies of Success,  
β = -.85, p < .05 
High Expectancies of Success,    
β = -1.72, p < .001 
